passiv
immunotherapi
driven
neutral
human
mab
could
effect
candid
prophylaxi
treatment
sarscov
infect
neutral
antibodi
respons
sarscov
protein
could
broadli
elicit
viru
infect
demonstr
longlast
immun
sera
recov
sar
patient
human
mab
sarscov
evalu
anim
model
demonstr
efficaci
human
mab
exampl
may
larg
reduc
viral
replic
given
prophylaxi
mice
dose
therapeut
achiev
human
accord
robert
et
al
therapi
neutral
human
mab
sarscov
reduc
diseas
sever
viral
burden
golden
syrian
hamster
fact
suggest
neutral
mab
may
use
import
emerg
prophylaxi
help
rapidli
clear
viru
thu
provid
immedi
protect
human
popul
event
sar
outbreak
previous
mention
mechan
mab
antivir
agent
may
vari
depend
target
epitop
region
mab
target
epitop
within
rbd
report
coughlin
et
al
other
interfer
interact
block
attach
viru
target
cell
thu
provid
protect
sarscov
replic
mab
test
coughlin
et
al
studi
target
domain
upstream
rbd
inhibit
viral
entri
postbind
event
sinc
human
mab
inhibit
sarscov
infect
differ
mechan
combin
mab
variou
mechan
inhibit
target
multipl
antigen
epitop
may
induc
addit
synergist
effect
larg
reduc
possibl
neutral
escap
mutant
gener
studi
rockx
et
al
indic
cocktail
three
mab
target
distinct
epitop
complet
protect
age
mice
weight
loss
viru
replic
lung
follow
lethal
challeng
live
sarscov
minim
like
gener
escap
mutant
enhanc
protect
effect
combin
mab
recogn
distinct
neutral
epitop
confirm
current
studi
overal
understand
mechan
action
underli
antivir
activ
mab
instrument
design
develop
novel
therapeut
treatment
sarscov
infect
conclus
immunotherapi
human
protect
antibodi
shown
prophylact
therapeut
potenti
sarscov
infect
anim
model
thu
provid
import
basi
clinic
trial
mab
human
popul
use
sarscovspecif
human
mab
prophylaxi
may
provid
safe
feasibl
efficaci
way
prevent
viru
infect
thu
serv
altern
signific
intervent
vaccin
howev
caution
taken
use
neutral
human
mab
immunoprophylaxi
strategi
genotyp
surveil
sarscovlik
genotyp
known
anim
reservoir
might
requir
note
passiv
transfer
antibodi
may
less
effici
protect
immunosenesc
popul
young
popul
expect
even
effect
neutral
mab
target
multipl
epitop
sarscov
contain
differ
mechan
could
develop
test
prevent
sar
infect
treatment
sar
patient
